ERSP

Electronic Retailing Self-Regulation Program

ERSP Recommends Coffee Shop Millionaire Discontinue Certain Claims for Lead-Generation Program; Company Agrees to Do So

ERSP has recommended that Coffee Shop Millionaire Education, Inc. modify or discontinue certain claims for the company’s “Coffee Shop Millionaire,” a lead-generation affiliate marketing business.

Read More

ERSP Finds Sleep Science Partners Can Support Performance Claims for ‘PureSleep,’ Recommends Marketer Discontinue Certain Claims

ERSP has determined that Sleep Science Partners provided adequate support for general performance claims made in direct response advertising for PureSleep, a device intended to treat nighttime snoring.

Read More

ERSP Finds Innerthrive Can Support General Performance Claims for ‘Ultimate Natural Testosterone System,’ Recommends Marketer Discontinue Certain Claims

ERSP has determined that Innerthrive, LLC, can support general performance claims for Ultimate Natural Testosterone System, a dietary supplement intended to increase testosterone levels.

Read More

ERSP Refers Advertising for ‘Mini Site Formula ‘Affiliate Marketing Program to FTC for Further Review

ERSP will refer direct response advertising for The Mini Site Formula Affiliate Marketing Program to the Federal Trade Commission (FTC) after the marketer, The Info Marketing Group, Inc., failed to respond to an ERSP inquiry.

Read More

ERSP Recommends Affiliate Marketer ‘YES International’ Discontinue Claims Made in Testimonials; Marketer Agrees to Revise Claims at Issue

ERSP has recommended that YES International, LLC (d/b/a Vensure International, LLC and Novus North, LLC) modify or discontinue certain claims for YES International, a lead-generation affiliate marketing business.

Read More

ERSP Recommends Lunada Biomedical Discontinue Weight-Loss Claims for ‘Amberen,’ Marketer Agrees to Do So

ERSP recommended that Lunada Biomedical discontinue weight-loss and other claims made for Amberen, a dietary supplement marketed to menopausal women. ERSP found, however, the company could support claims related to hot flashes, irritability, sleeplessness, and “low libido.”

Read More